To further investigate the therapeutic value of vitamin C for the destruction of CRC cells with high GLUT3 expression, we tested the impact of vitamin C alone as well as in combination with the common anticancer agent oxaliplatin (L-OHP) on CRC cell growth. This evidence concerns the gene SLC2A3 and colorectal carcinoma.